Champions Oncology, Inc. (CSBR) Social Stream
Champions Oncology Inc (CSBR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CSBR.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 22, 2022
The Trend in the Analyst Price Target
CSBR's average price target has moved down $2.67 over the prior 33 weeks.
CSBR reports an average of 54.77% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CSBR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Champions Oncology Inc's number of analysts covering the stock is higher than practically none of all US stocks.
- In the context of Pharmaceutical Products stocks, Champions Oncology Inc's variance in analysts' estimates is lower than 90.04% of them.
- In the context of Healthcare stocks, Champions Oncology Inc's average analyst price target is greater than 73.14% of them.
- In terms of how Champions Oncology Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 87.47% of that group.
Is CSBR a Buy, Hold or Sell? See the POWR Ratings now!